Melox

Meloxicam, the active ingredient in Melox, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an intramuscular injection for intramuscular use. It is indicated for managing osteoarthritis, rheumatoid arthritis, acute musculoskeletal pain, and post‑operative pain in adult patients.

GNH USA supplies Melox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured batches and reliable logistics across regulated markets. The company adheres to EU GMP standards and provides full documentation for regulatory review. Customer support is available for technical queries and post‑sale service.

Meloxicam is used to treat inflammatory and painful conditions affecting the musculoskeletal system.

Osteoarthritis: reduces joint pain and inflammation, improving functional mobility. Rheumatoid arthritis: alleviates synovial inflammation and joint tenderness, helping to maintain range of motion. Acute musculoskeletal pain: provides rapid analgesia for sprains, strains, and soft‑tissue injuries. Post‑operative pain: controls postoperative inflammatory pain, facilitating early rehabilitation.

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort (nausea, dyspepsia) - Headache - Dizziness - Injection site pain or erythema - Mild elevation of liver enzymes

Serious or Rare Side Effects: - Peptic ulcer disease or gastrointestinal bleeding - Severe skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis) - Renal impairment or acute kidney injury - Hepatotoxicity with marked transaminase rise - Anaphylactic or severe hypersensitivity reactions

When prescribing meloxicam injection, clinicians should observe several safety considerations. - Renal function: assess baseline kidney function and monitor during therapy. - Cardiovascular risk: avoid in patients with uncontrolled hypertension or recent myocardial infarction. - Gastrointestinal history: use cautiously in individuals with prior ulcer disease or bleeding. - Concomitant anticoagulants: monitor for increased bleeding risk. - Pregnancy and lactation: avoid unless benefit outweighs potential risk, as safety data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meloxicam can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective COX‑2 inhibitors (e.g., celecoxib): additive cardiovascular toxicity. - Lithium: meloxicam may raise lithium serum levels, risking toxicity. - Methotrexate: potential for enhanced methotrexate toxicity. - Cyclosporine: may increase nephrotoxic risk.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce renal clearance of meloxicam. - ACE inhibitors or ARBs: possible reduction in renal function. - SSRIs or SNRIs: modest increase in bleeding tendency. - Beta‑blockers: may blunt antihypertensive effect. - Allopurinol: occasional elevation of meloxicam plasma concentrations.